MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Libby's H*O*P*E*' source. Fri, 24 Oct 2008 16:19:27 +0100 http://healthinfoispower.wordpress.com/2008/10/08/fda-issues-a-warning-letter-to-labcorp-regarding-the-illegal-marketing-of-the-ovasure%e2%84%a2-test/ On September 29, 2008, the U.S. Food and Drug Administration (FDA) Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health, issued a warning letter (FDA Warning Letter) to the Chief Executive Officer of the Laboratory Corporation of America (LabCorp) regarding the illegal marketing of the OvaSure™ ovarian cancer [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1860605 Wed, 08 Oct 2008 19:39:45 +0100 1860605 http://healthinfoispower.wordpress.com/2008/09/07/mk-0457-alone-and-in-combination-with-docetaxel-inhibits-ovarian-cancer-growth-in-vivo/ …[T]he [M.D. Anderson Cancer Center & Baylor College of Medicine] researchers concluded that [Aurora kinase] AK inhibition [produced by MK-0457] significantly reduces ovarian cancer tumor burden and cell proliferation, and increases tumor cell apoptosis in preclinical ovarian cancer mouse models. The researchers noted that the role of Aurora kinase inhibition in ovarian cancer merits further [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1773566 Mon, 08 Sep 2008 00:49:39 +0100 1773566 http://healthinfoispower.wordpress.com/2008/09/05/what-do-you-stand-for-standup2cancer-tonight/ This year, approximately 565,650 Americans are expected to die of cancer — that’s more than 1,500 people a day. … Ovarian cancer causes more deaths than any other cancer of the female reproductive system. … In an unprecedented television event, NBC, ABC, and CBS will simultaneously devote 1 hour of commercial-free prime time to [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1769856 Fri, 05 Sep 2008 22:23:53 +0100 1769856 http://healthinfoispower.wordpress.com/2008/09/02/hollywood-celebs-raise-awareness-regarding-hereditary-breast-and-ovarian-cancer/ Christina Applegate - Samantha Who? Recently diagnosed in July 2008 with breast cancer, Christina Applegate appeared on ABC’s Good Morning America program in August. The talented, Emmy award winning actress is currently the star of the ABC sitcom “Samantha Who?” Applegate came into the Hollywood limelight when she appeared in popular Fox sitcom “Married [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1756994 Wed, 03 Sep 2008 16:43:56 +0100 1756994 http://healthinfoispower.wordpress.com/2008/08/29/nbocc-runwalk-for-her-september-21-2008/ On Sunday, September 21, 2008, the National Breast and Ovarian Cancer Coalition (NBOCC) will conduct its annual 5K Run/3K Walk for Her. This walk is dedicated to those who have lost the battle to breast or ovarian cancer, and celebrates those who continue to fight. The event will start at 8:00 A.M. EDT and [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1744475 Fri, 29 Aug 2008 20:21:14 +0100 1744475 http://healthinfoispower.wordpress.com/2008/08/28/presidential-proclamation-begins-national-ovarian-cancer-awareness-month-september-2008/ “During National Ovarian Cancer Awareness Month, we remember those whose lives have been affected by this deadly disease, and we underscore our commitment to battling ovarian cancer for the sake of women around the world. …” “For Immediate Release Office of the Press Secretary August 26, 2008 National Ovarian Cancer Awareness Month, 2008 A Proclamation by the President of the [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1740472 Fri, 29 Aug 2008 01:00:58 +0100 1740472 http://healthinfoispower.wordpress.com/2008/08/23/lost-in-translation-fda-believes-that-labcorps-ovarian-cancer-early-detection-test-ovasure-lacks-adequate-clinical-validation/ The U.S. Food and Drug Administration (FDA) sent a letter to the Laboratory Corporation of America (LabCorp) on August 7, 2008, stating that it believes the Yale ovarian cancer early detection test (marketed by LabCorp under the name OvaSure™) ” … has not received adequate clinical validation, and may harm the public health.” In that [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1729819 Sun, 24 Aug 2008 16:17:19 +0100 1729819 http://healthinfoispower.wordpress.com/2008/08/21/imatinib-docetaxel-produce-modest-response-against-recurrent-platinum-resistantrefractory-ovarian-cancer/ A combination of imatinib mesylate (Gleevec®) and docetaxel (Taxotere®) produced only a modest response in patients with recurrent, platinum-resistant or refractory ovarian cancer, according to the results of a Phase II clinical trial conducted by the Hoosier Oncology Group at Indiana University Cancer Center. Background A combination of imatinib mesylate (Gleevec®) and docetaxel (Taxotere®) produced only a [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727796 Fri, 22 Aug 2008 06:58:19 +0100 1727796 http://healthinfoispower.wordpress.com/2008/08/19/patty-franchi-flaherty-loses-battle-to-ovarian-cancer-but-deserves-a-long-standing-ovation/ It is with deep regret that I must inform you that, Patty Franchi Flaherty, founder of the nonprofit organization Ovations for the Cure of Ovarian Cancer, peacefully succumbed to her nine-year battle with the disease on August 18, 2008, surrounded by friends and family. She was 53 years old. Patty was a legendary ovarian cancer [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727797 Tue, 19 Aug 2008 19:34:58 +0100 1727797 http://healthinfoispower.wordpress.com/2008/08/18/working-smarter-not-harder-anti-estrogen-therapy-to-battle-recurrent-ovarian-cancer/ The Gynecologic Oncology department of the University of Texas, M.D. Anderson Cancer Center took a page out of the breast cancer treatment “playbook,” and conducted a single institution Phase II clinical trial using letrozole (Femara®) to treat recurrent, platinum and taxane resistant, high-grade cancer of the ovary and peritoneum. …The trial investigators concluded that 26% [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727798 Tue, 19 Aug 2008 03:28:31 +0100 1727798 http://healthinfoispower.wordpress.com/2008/08/17/winners-walk-of-hope-ovarian-cancer-canada-takes-steps-to-eradicate-the-disease-that-whispers/ “On Sunday, September 7th, 14 Canadian cities will join in the only national fundraising event dedicated to overcoming ovarian cancer - the Winners Walk of Hope. … The annual walk has raised more than $3-million for ovarian cancer support and awareness programs across the country, including resources for newly diagnosed women; awareness campaigns targeted at [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727799 Mon, 18 Aug 2008 02:02:15 +0100 1727799 http://healthinfoispower.wordpress.com/2008/08/17/cancer-survivors-with-low-volume-metastases-may-benefit-from-radiotherapy/ “Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. … Six of the 29 [21%] initial patients had lasting tumor control, with no detectable evidence of disease 15 months after treatment. [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727800 Mon, 18 Aug 2008 00:52:51 +0100 1727800 http://healthinfoispower.wordpress.com/2008/08/13/a-celebration-of-libbys-life/ Elizabeth Kay Remick passed away peacefully at 11:33 A.M. on Monday, July 28, at home with family by her side. Our family was blessed with Libby’s presence for 26 years. She battled ovarian cancer for 18 months with courage and an indomitable spirit. A celebration of Libby’s life will be held on August 17th [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727801 Thu, 14 Aug 2008 06:56:03 +0100 1727801 http://healthinfoispower.wordpress.com/2008/08/03/combination-targeted-therapy-with-sorafenib-bevacizumab-shows-antitumor-activity/ The results from a recent Phase I solid tumor clinical trial indicate that combination targeted therapy with sorafenib and bevacizumab produces anti-tumor activity (and enhanced toxicity) with respect to 43% of the ovarian cancer patients enrolled in that trial. Sorafenib (Nexavar®) inhibits the Raf kinase and vascular endothelial growth factor (VEGF) receptor. Bevacizumab (Avastin®) is [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727802 Mon, 04 Aug 2008 02:36:13 +0100 1727802 http://healthinfoispower.wordpress.com/2008/07/29/the-emerging-field-of-oncofertility/ “Welcome to the burgeoning world of oncofertility. As cancer survival rates climb and patients focus on quality-of-life issues, especially fertility, Dauer and others like her are forcing two very different medical specialties-oncology and assisted reproduction-to come together. ‘The narrative of cancer is no longer that it’s a death sentence; it’s a bump in your [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727803 Tue, 29 Jul 2008 18:35:49 +0100 1727803 http://healthinfoispower.wordpress.com/2008/07/29/non-platinum-topotecan-drug-combination-therapy-provides-no-survival-advantage-over-topotecan-monotherapy/ “In women with recurrent ovarian cancer, treatment with topotecan along with etoposide or gemcitabine offers no survival advantage over topotecan monotherapy, German and Austrian researchers report in the July 1st issue of the Journal of Clinical Oncology.” “In women with recurrent ovarian cancer, treatment with topotecan along with etoposide or gemcitabine offers no survival advantage over [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727804 Tue, 29 Jul 2008 18:33:33 +0100 1727804 http://healthinfoispower.wordpress.com/2008/07/28/a-requiem-hallelujah-dont-let-there-be-a-hole-in-the-world-tomorrow/ As many of you know, the H*O*P*E*™ weblog is dedicated to Libby, my 26 year old cousin. Libby was diagnosed with ovarian clear cell carcinoma in January 2007. I am deeply saddened to inform you that Libby lost her battle to ovarian cancer this morning with her family at her side. Libby [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727805 Mon, 28 Jul 2008 23:35:32 +0100 1727805 http://healthinfoispower.wordpress.com/2008/07/23/from-zero-to-hero-hmgb1-protein-found-to-promote-dna-repair-prevents-cancer/ “An abundant chromosomal protein [HMGB1] that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academies of Science.” “An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727806 Wed, 23 Jul 2008 20:42:04 +0100 1727806 http://healthinfoispower.wordpress.com/2008/07/22/fashion-really-can-make-a-statement-in-the-fight-against-ovarian-cancer/ Kelly Ripa and Molly Sims are fighting for a cure by doing something they love — shop! It’s all a part of Super Saturday Live on QVC. QVC will offer designer clothing, jewelry, beauty products, and accessories at 30% to 50% off of the manufacturer’s suggested retail price. All of the net proceeds [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727807 Wed, 23 Jul 2008 04:19:45 +0100 1727807 http://healthinfoispower.wordpress.com/2008/07/21/tp53-gene-mutation-found-in-80-of-high-grade-ovarian-serous-carcinomas-tp53-not-directly-involved-in-the-development-of-drug-resistance/ “… [T]he [Johns Hopkins] research team concluded that the frequency of TP53 gene mutations using purified tumor DNA from ovarian serous carcinomas was 80.3%, which is much higher than previously reported in the medical literature. Furthermore, the research team found that TP53 is not directly involved in the development of drug resistance in high-grade ovarian [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727808 Tue, 22 Jul 2008 05:42:32 +0100 1727808 http://healthinfoispower.wordpress.com/2008/07/16/pov-documentary-in-the-family-one-womans-journey-through-the-unpredictable-world-of-predicative-genetic-testing/ “At the age of 27, filmmaker Joanna Rudnick tested positive for the BRCA mutation. Joanna now faces an impossible decision: remove her healthy breasts and ovaries or risk incredible odds of developing cancer. Armed with a positive test result that leaves her essentially “a ticking time bomb,” she balances dreams of having her [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727809 Wed, 16 Jul 2008 22:51:22 +0100 1727809 http://healthinfoispower.wordpress.com/2008/07/15/md-anderson-identifies-tg2-as-a-potential-target-in-chemo-resistant-ovarian-cancer/ “Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1727810 Tue, 15 Jul 2008 19:48:53 +0100 1727810